RSS-Feed abonnieren
DOI: 10.1055/s-0036-1581080
Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes
Publikationsverlauf
24. Oktober 2015
12. Februar 2016
Publikationsdatum:
08. April 2016 (online)
![](https://www.thieme-connect.de/media/ajp/201609/lookinside/thumbnails/10-1055-s-0036-1581080_150386-1.jpg)
Abstract
Objective The objective of this study was to describe the indications for postnatal cytomegalovirus (CMV) testing among very low-birth-weight (VLBW, birth weight [BW] < 1,500 g) infants, clinical characteristics of infected infants, and adverse outcomes associated with CMV infection.
Study Design This is a single-center, retrospective study of 2,132 VLBW infants from 1999 to 2013.
Results In this study, 145 (6.8%) infants out of 2,132 were evaluated for postnatal CMV infection and 27 (18.6%) infants out of 145 were infected. CMV-tested infants were of significantly lower gestational age and BW compared with untested VLBW infants (p < 0.001). Respiratory decompensation and thrombocytopenia were the findings most commonly associated with infection. CMV-infected infants had significantly more exposure to mechanical ventilation and longer duration of hospitalization. Adjusting for multiple predictors of respiratory morbidity, the incidence of bronchopulmonary dysplasia (BPD) was significantly elevated among infants diagnosed with postnatal CMV infection (odds ratio, 4.0 [95% confidence interval, 1.3–12.4); p, 0.02.)
Conclusion Symptomatic postnatal CMV infection was diagnosed in 1.3% of VLBW infants, most commonly among infants with BW < 1,000 g with respiratory instability and thrombocytopenia. Similar to late-onset bacterial infection, symptomatic postnatal CMV infection may be an independent contributor to the development of BPD. This possibility should be addressed in a prospective study of extremely low BW infants.
-
References
- 1 Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001; 357 (9255) 513-518
- 2 Josephson CD, Caliendo AM, Easley KA , et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study. JAMA Pediatr 2014; 168 (11) 1054-1062
- 3 Miron D, Brosilow S, Felszer K , et al. Incidence and clinical manifestations of breast milk-acquired Cytomegalovirus infection in low birth weight infants. J Perinatol 2005; 25 (5) 299-303
- 4 Hamprecht K, Maschmann J, Jahn G, Poets CF, Goelz R. Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol 2008; 41 (3) 198-205
- 5 Jim WT, Shu CH, Chiu NC , et al. High cytomegalovirus load and prolonged virus excretion in breast milk increase risk for viral acquisition by very low birth weight infants. Pediatr Infect Dis J 2009; 28 (10) 891-894
- 6 Vollmer B, Seibold-Weiger K, Schmitz-Salue C , et al. Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants. Pediatr Infect Dis J 2004; 23 (4) 322-327
- 7 Neuberger P, Hamprecht K, Vochem M , et al. Case-control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants. J Pediatr 2006; 148 (3) 326-331
- 8 Hayashi S, Kimura H, Oshiro M , et al. Transmission of cytomegalovirus via breast milk in extremely premature infants. J Perinatol 2011; 31 (6) 440-445
- 9 Capretti MG, Lanari M, Lazzarotto T , et al. Very low birth weight infants born to cytomegalovirus-seropositive mothers fed with their mother's milk: a prospective study. J Pediatr 2009; 154 (6) 842-848
- 10 Goelz R, Meisner C, Bevot A, Hamprecht K, Kraegeloh-Mann I, Poets CF. Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk. Arch Dis Child Fetal Neonatal Ed 2013; 98 (5) F430-F433
- 11 Dorn M, Lidzba K, Bevot A, Goelz R, Hauser TK, Wilke M. Long-term neurobiological consequences of early postnatal hCMV-infection in former preterms: a functional MRI study. Hum Brain Mapp 2014; 35 (6) 2594-2606
- 12 Bevot A, Hamprecht K, Krägeloh-Mann I, Brosch S, Goelz R, Vollmer B. Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk. Acta Paediatr 2012; 101 (4) e167-e172
- 13 Nijman J, van Zanten BG, de Waard AK, Koopman-Esseboom C, de Vries LS, Verboon-Maciolek MA. Hearing in preterm infants with postnatally acquired cytomegalovirus infection. Pediatr Infect Dis J 2012; 31 (10) 1082-1084
- 14 Lanzieri TM, Dollard SC, Josephson CD, Schmid DS, Bialek SR. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics 2013; 131 (6) e1937-e1945
- 15 Luck S, Sharland M. Postnatal cytomegalovirus: innocent bystander or hidden problem?. Arch Dis Child Fetal Neonatal Ed 2009; 94 (1) F58-F64
- 16 Buxmann H, Falk M, Goelz R, Hamprecht K, Poets CF, Schloesser RL. Feeding of very low birth weight infants born to HCMV-seropositive mothers in Germany, Austria and Switzerland. Acta Paediatr 2010; 99 (12) 1819-1823
- 17 Gunkel J, Wolfs TF, de Vries LS, Nijman J. Predictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment. Expert Rev Anti Infect Ther 2014; 12 (11) 1345-1355
- 18 Mehler K, Oberthuer A, Lang-Roth R, Kribs A. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22–24 weeks' gestation after transmission via breast milk. Neonatology 2014; 105 (1) 27-32
- 19 Sawyer MH, Edwards DK, Spector SA. Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants. Am J Dis Child 1987; 141 (3) 303-305
- 20 Okulu E, Akin IM, Atasay B, Ciftçi E, Arsan S, Türmen T. Severe postnatal cytomegalovirus infection with multisystem involvement in an extremely low birth weight infant. J Perinatol 2012; 32 (1) 72-74
- 21 Papazian L, Fraisse A, Garbe L , et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996; 84 (2) 280-287
- 22 Yeager AS, Palumbo PE, Malachowski N, Ariagno RL, Stevenson DK. Sequelae of maternally derived cytomegalovirus infections in premature infants. J Pediatr 1983; 102 (6) 918-922
- 23 Prösch S, Lienicke U, Priemer C , et al. Human adenovirus and human cytomegalovirus infections in preterm newborns: no association with bronchopulmonary dysplasia. Pediatr Res 2002; 52 (2) 219-224
- 24 Pinninti SG, Ross SA, Shimamura M , et al; National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Comparison of saliva PCR assay versus rapid culture for detection of congenital cytomegalovirus infection. Pediatr Infect Dis J 2015; 34 (5) 536-537
- 25 Turner KM, Lee HC, Boppana SB, Carlo WA, Randolph DA. Incidence and impact of CMV infection in very low birth weight infants. Pediatrics 2014; 133 (3) e609-e615
- 26 Vohr BR, Poindexter BB, Dusick AM , et al; NICHD Neonatal Research Network. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics 2006; 118 (1) e115-e123
- 27 Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007; 27 (7) 428-433
- 28 Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129 (3) e827-e841
- 29 Maschmann J, Hamprecht K, Weissbrich B, Dietz K, Jahn G, Speer CP. Freeze-thawing of breast milk does not prevent cytomegalovirus transmission to a preterm infant. Arch Dis Child Fetal Neonatal Ed 2006; 91 (4) F288-F290
- 30 Oliver SE, Cloud GA, Sánchez PJ , et al; National Institute of Allergy, Infectious Diseases Collaborative Antiviral Study Group. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 2009; 46 (Suppl. 04) S22-S26
- 31 Kimberlin DW, Lin CY, Sánchez PJ , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143 (1) 16-25
- 32 Kimberlin DW, Jester PM, Sánchez PJ , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015; 372 (10) 933-943